Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Part 3: How to test
PARP inhibition in the treatment of prostate cancer
Part 3: How to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Prostate cancer screening using prostate-specific antigen, a multiplex blood-tes...
Prof Martin Eklund - Karolinska Institutet, Solna, Sweden
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies ( Prof Martin Eklund - Karolinska Institutet, Solna, Sweden )
20 Jul 2021
OncoAlert and ecancer weekly round up for July 12- July 18, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for July 12- July 18, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
19 Jul 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer ( Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy )
19 Jul 2021
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600...
Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain
Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer ( Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain )
13 Jul 2021
New Director of the Cicely Saunders Institute at King’s College London
Prof Richard Harding - King's College London, London, UK
New Director of the Cicely Saunders Institute at King’s College London ( Prof Richard Harding - King's College London, London, UK )
8 Jul 2021
FGFR as a tumour agnostic indicator and its importance in the diagnosis and trea...
Dr Christophe Massard and Prof Eva Compérat
FGFR as a tumour agnostic indicator and its importance in the diagnosis and treatment of multiple solid tumour types ( Dr Christophe Massard and Prof Eva Compérat )
1 Jul 2021
ASCO 2021: Precision and molecular reporting for prostate cancer
Prof Eleni Efstathiou - Houston Methodist Cancer Center, Houston, USA
ASCO 2021: Precision and molecular reporting for prostate cancer ( Prof Eleni Efstathiou - Houston Methodist Cancer Center, Houston, USA )
29 Jun 2021
Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative ch...
Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland
Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy ( Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland )
29 Jun 2021
COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory ...
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
COSMIC-311: Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
29 Jun 2021
The clinical value of maintenance in multiple myeloma
Prof Wee Joo Chng - National University of Singapore, Singapore
The clinical value of maintenance in multiple myeloma ( Prof Wee Joo Chng  - National University of Singapore, Singapore )
25 Jun 2021
Once weekly selinexor, carfilzomib, and dexamethasone (XKD) in carfilzomib non-r...
Prof Cristina Gasparetto - Duke Cancer Institute, Durham, USA
Once weekly selinexor, carfilzomib, and dexamethasone (XKD) in carfilzomib non-refractory multiple myeloma patients ( Prof Cristina Gasparetto - Duke Cancer Institute, Durham, USA )
25 Jun 2021